Bemcentinib,Pembrolizumab
BerGenBio,Merck
['pembro', 'mesothelioma', 'lcsm,(-blcsm)', 'bemcentinib']
#asco23 #mist3 ph 2a trial of #bemcentinib (axl inhibitor) + pembro after chemo relapse for #mesothelioma n=26
orr 15.4%
sd 57.7% molecular correlates presented #lcsm 
Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed